Page last updated: 2024-08-23

amikacin and pefloxacin

amikacin has been researched along with pefloxacin in 34 studies

Research

Studies (34)

TimeframeStudies, this research(%)All Research%
pre-199016 (47.06)18.7374
1990's10 (29.41)18.2507
2000's5 (14.71)29.6817
2010's3 (8.82)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Courvalin, P; Galimand, M; Périchon, B1
Lombardo, F; Obach, RS; Waters, NJ1
Cattoir, V; Nordmann, P; Poirel, L1
Girlich, D; Nordmann, P; Poirel, L1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Bush, V; Korshunov, VM; Romanchuk, LA1
Busch, W; Dugasheva, LG; Gorodinskaia, VS; Il'chenko, AA; Korshunov, VM; Radakova, ED; Romanchuk, LA; Zhukhovitskiĭ, VG1
Beuscart, C; Drugeon, H; Leroy, O; Mouton, Y; Pappo, M2
Amrani, R; Beklahia, C; Labia, R; Morand, A; Verchere-Beaur, C1
Chaste, A; Combremont, AG; David, C; Saison, C1
Auckenthaler, R; Marchou, B; Michéa-Hamzehpour, M; Pechère, JC2
Husson, M; Klastersky, J; Lauzon, D; Lieppe, S; Lopez, AP; Van der Auwera, P1
Bayer, AS; Hirano, L; Yih, J1
Claeys, G; Van den Abeele, AM; Verschraegen, G1
de Micco, P; Gevaudan, MJ; Gulian, C; Lagier, P; Mallet, MN; Terriou, P1
Boisivon, A; Guiomar, C; Gutmann, L1
Auzepy, P; Pezzano, M; Richard, C; Singlas, E; Sultan, E1
Berlioux, J; Daguet, GL; Mugnier, P; Pasteau, C; Ygout, JF1
Durgham, SM; Ishag, AJ; Shibl, AM1
Auzepy, P; Richard, C; Singlas, E; Sultan, E1
Bouillet, L; Husson, MO; Izard, D; Leclerc, H1
Carbon, C; Cochereau, I; Marrakchi-Benjaafar, S; Pocidalo, JJ1
Anastassiadou, H; Dassiou, M; Samonis, G1
Bayle, C; Bourhis, JH; Cartron, J; Gautier, E; Pico, JL; Tchernia, G1
Majtán, V; Majtánová, L2
Alamowitch, B; Bethoux, JP; Bouillot, JL; Fourmestraux, J; Ghossain, M; Sellam, P; Thomas, F1
Mayer, I; Nagy, E2
Qin, X; Xiao, G; Xu, N; Yuan, J; Zheng, J1
Dekens, J; Fodzo, E; Popesco, D; Tchaoussoff, J; Yagoubi, A1

Trials

2 trial(s) available for amikacin and pefloxacin

ArticleYear
[Prospective randomized controlled study of a ceftazidime and pefloxacin combination versus a ceftazidime and amikacin combination in the empirical treatment of pneumonia and nosocomial septicemia at intensive care units].
    Pathologie-biologie, 1989, Volume: 37, Issue:5

    Topics: Amikacin; Ceftazidime; Cross Infection; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Multicenter Studies as Topic; Pefloxacin; Pneumonia; Prospective Studies; Random Allocation; Sepsis

1989
[Controlled randomized prospective study of a ceftazidime-pefloxacin combination versus a ceftazidime-amikacin combination in the empirical treatment of nosocomial pneumonias and septicemias of resuscitation. Preliminary results].
    Presse medicale (Paris, France : 1983), 1988, Oct-26, Volume: 17, Issue:37

    Topics: Amikacin; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Pefloxacin; Pneumonia; Prospective Studies; Random Allocation

1988

Other Studies

32 other study(ies) available for amikacin and pefloxacin

ArticleYear
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids

2008
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
[Selective decontamination of the intestine and total gnotobiologic isolation in treatment of mice with acute radiation sickness].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1992, Volume: 37, Issue:1

    Topics: Acute Disease; Amikacin; Animals; Ciprofloxacin; Decontamination; Germ-Free Life; Intestines; Mice; Mice, Inbred CBA; Opportunistic Infections; Pefloxacin; Radiation Injuries, Experimental

1992
[The experimental and clinical effect of ciprofloxacin on the microflora of the gastrointestinal tract].
    Zhurnal mikrobiologii, epidemiologii i immunobiologii, 1991, Issue:5

    Topics: Adult; Amikacin; Animals; Cimetidine; Ciprofloxacin; Digestive System; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Duodenal Ulcer; Female; Germ-Free Life; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mice; Mice, Inbred CBA; Middle Aged; Pefloxacin; Time Factors

1991
[Enzymologic aspect of piperacillin combinations].
    Presse medicale (Paris, France : 1983), 1986, Dec-20, Volume: 15, Issue:46

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Drug Therapy, Combination; Enterobacter; Enzyme Induction; Hydrolysis; Norfloxacin; Pefloxacin; Piperacillin; Pseudomonas aeruginosa

1986
[In vitro effect of combinations of netilmicin and amikacin with fosfomycin and pefloxacin on 31 strains of heterogeneous methicillin- resistant Staphylococcus aureus].
    Pathologie-biologie, 1988, Volume: 36, Issue:5 Pt 2

    Topics: Amikacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Humans; In Vitro Techniques; Methicillin; Microbial Sensitivity Tests; Netilmicin; Pefloxacin; Staphylococcal Infections; Staphylococcus aureus

1988
Emergence of resistance after therapy with antibiotics used alone or combined in a murine model.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 17 Suppl A

    Topics: Amikacin; Animals; Bacteria; Bacterial Infections; Ceftriaxone; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Escherichia coli; Female; Kanamycin; Klebsiella pneumoniae; Mice; Norfloxacin; Pefloxacin; Peritonitis; Pseudomonas aeruginosa; Serratia marcescens; Staphylococcus aureus

1986
Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.
    Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:2

    Topics: Amikacin; Ampicillin; Cephalothin; Drug Combinations; Drug Interactions; Enterobacteriaceae; Escherichia coli; Female; Humans; Infusions, Parenteral; Kanamycin; Klebsiella pneumoniae; Male; Norfloxacin; Oxacillin; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus aureus; Ticarcillin

1986
Combination therapy: a way to limit emergence of resistance?
    The American journal of medicine, 1986, Jun-30, Volume: 80, Issue:6B

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia marcescens; Staphylococcal Infections; Staphylococcus aureus; Time Factors

1986
Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis.
    Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:2

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits

1988
Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240).
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988, Volume: 7, Issue:1

    Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefaclor; Ceftazidime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Corynebacterium; Drug Combinations; Drug Resistance, Microbial; Fleroxacin; Norfloxacin; Pefloxacin; Piperacillin; Staphylococcus; Vancomycin

1988
[Sensitivity of 7 mycobacterial species to new quinolones].
    Pathologie-biologie, 1988, Volume: 36, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Drug Synergism; Erythromycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Sulfamethoxazole; Thienamycins; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination

1988
Interaction between piperacillin and pefloxacin or amikacin on the selection of resistant mutants of Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 1988, Volume: 22, Issue:5

    Topics: Amikacin; beta-Lactamases; Drug Interactions; Microbial Sensitivity Tests; Mutation; Pefloxacin; Phenotype; Piperacillin; Pseudomonas aeruginosa; Selection, Genetic

1988
Pharmacokinetics of pefloxacin and amikacin administered simultaneously to intensive care patients.
    European journal of clinical pharmacology, 1988, Volume: 34, Issue:6

    Topics: Aged; Amikacin; Bacterial Infections; Drug Interactions; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Intensive Care Units; Male; Middle Aged; Pefloxacin

1988
[Phenotypes of resistance to antibiotics of Acinetobacter baumannii. Impact on therapeutic orientation].
    Pathologie-biologie, 1988, Volume: 36, Issue:3

    Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Norfloxacin; Pefloxacin; Phenotype; Thienamycins

1988
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Clindamycin; Fusidic Acid; Imipenem; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcus aureus; Thienamycins; Tobramycin; Vancomycin

1987
Pharmacokinetics of pefloxacin and amikacin administered simultaneously to patients undergoing resuscitation.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl

    Topics: Aged; Amikacin; Drug Therapy, Combination; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Norfloxacin; Pefloxacin; Resuscitation

1987
In vitro activity of pefloxacin.
    Drugs under experimental and clinical research, 1986, Volume: 12, Issue:4

    Topics: Amikacin; Anti-Infective Agents; Cefotaxime; Ceftazidime; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance

1986
Systemic prophylaxis of experimental staphylococcal endophthalmitis: comparative efficacy of sparfloxacin, pefloxacin, imipenem, vancomycin, and amikacin.
    The Journal of infectious diseases, 1995, Volume: 172, Issue:5

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Eye; Eye Infections, Bacterial; Female; Fluoroquinolones; Imipenem; Pefloxacin; Quinolones; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

1995
Antibiotics affecting gastrointestinal colonization of mice by yeasts.
    Journal of chemotherapy (Florence, Italy), 1994, Volume: 6, Issue:1

    Topics: Amikacin; Amoxicillin; Animals; Anti-Bacterial Agents; Candida albicans; Candidiasis; Cefotaxime; Digestive System; Disease Models, Animal; Feces; Gastrointestinal Diseases; Male; Mice; Mice, Inbred ICR; Pefloxacin

1994
Parvovirus B19 associated neutropenia. Treatment with Rh G-CSF.
    Hematology and cell therapy, 1997, Volume: 39, Issue:2

    Topics: Adenocarcinoma; Adult; Amikacin; Colonic Neoplasms; DNA, Viral; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intravenous; Liver Neoplasms; Neutropenia; Parvoviridae Infections; Parvovirus B19, Human; Pefloxacin; Penicillanic Acid; Piperacillin; Recombinant Proteins; Tazobactam

1997
Postantibiotic effects and postantibiotic sub-MIC effects of ciprofloxacin, pefloxacin and amikacin on the biological properties of Salmonella strains.
    Folia microbiologica, 1997, Volume: 42, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriophages; Cell Wall; Chemical Phenomena; Chemistry, Physical; Ciprofloxacin; Coloring Agents; Congo Red; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Pefloxacin; Salmonella enteritidis; Salmonella Phages; Salmonella typhimurium; Virus Activation

1997
Postantibiotic effect of some antibiotics on the metabolism of Pseudomonas aeruginosa.
    Journal of basic microbiology, 1998, Volume: 38, Issue:3

    Topics: Adenine; Amikacin; Anti-Bacterial Agents; Carbon Radioisotopes; Cell Division; Ciprofloxacin; Imipenem; Leucine; Meropenem; Nucleic Acid Synthesis Inhibitors; Oxygen Consumption; Pefloxacin; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Thienamycins

1998
[Emphysematous cystitis: report of a case].
    Presse medicale (Paris, France : 1983), 1998, Apr-25, Volume: 27, Issue:16

    Topics: Amikacin; Amoxicillin; Anti-Infective Agents, Urinary; Cystitis; Emphysema; Follow-Up Studies; Humans; Male; Middle Aged; Pefloxacin; Penicillins; Tomography, X-Ray Computed; Ultrasonography; Urinary Retention

1998
Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefoperazone; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Netilmicin; Pefloxacin; Pseudomonas

1999
[An experimental study on the release of endotoxin from gram negative bacteria induced by antibiotics].
    Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns, 2001, Volume: 17, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Dose-Response Relationship, Drug; Endotoxins; Escherichia coli; Gram-Negative Bacteria; Imipenem; Lipopolysaccharides; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Pefloxacin; Pseudomonas aeruginosa

2001
[Peridural abscess complicating spinal anesthesia in a diabetic patient].
    Annales francaises d'anesthesie et de reanimation, 1997, Volume: 16, Issue:8

    Topics: 4-Quinolones; Abscess; Amikacin; Anesthesia, Spinal; Anti-Infective Agents; Diabetes Mellitus, Type 2; Disease Susceptibility; Drainage; Drug Therapy, Combination; Epidural Space; Fluoroquinolones; Humans; Laminectomy; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Oxacillin; Pefloxacin; Postoperative Complications; Povidone-Iodine; Punctures; Quinolones; Spinal Diseases; Staphylococcal Infections

1997
Evaluation of post-antibiotic effects of antipseudomonal antibiotics using an automated system.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2000, Volume: 108, Issue:4

    Topics: 4-Quinolones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Automation; Ceftazidime; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Netilmicin; Ofloxacin; Pefloxacin; Pseudomonas; Pseudomonas aeruginosa; Pseudomonas Infections

2000